Wangdiantong has received a $14.5m capital injection from the $300m China Ventures Fund I, established last year by SoftBank Ventures Korea and TPG Growth.

Mars Petcare-backed vegan dog food producer Wild Earth has collected $11m in a series A round that took its total funding to $16m.

Adevinta formed part of a consortium that supplied $3.5m in series A funding to Kodit.io alongside a $10.5m loan to purchase real estate.

Lundbeckfond Ventures contributed to a round that will fund clinical trials for Reneo Pharmaceuticals' mitochondrial disease therapies.

M Ventures, Pfizer Ventures and Taiho Ventures all returned to help boost cancer drug developer Storm Therapeutics' series A round to $38.2m.

Quell Therapeutics will develop treatments for conditions such as solid organ transplant rejection and has also secured capital from UCL Technology Fund.

Cambridge's cancer drug spinout Storm Therapeutics convinced its existing investors to join new participant Seroba Life Sciences for a second extension that brought its series A total to $38.2m.

Brian Rothenberg has departed from ticketing platform developer Eventbrite where he oversaw the growth team for six years, to take up a partner position at Defy Partners.

Prefabricated housing developer Connect Homes now has corporate backing in the form of Wells Fargo Strategic Capital, which invested in its $10.8m series A.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.